Anna R Van Meter1, Coty Burke2, Eric A Youngstrom2, Gianni L Faedda3, Christoph U Correll4. 1. Ferkauf Graduate School at Yeshiva University, New York. Electronic address: anna.vanmeter@einstein.yu.edu. 2. University of North Carolina at Chapel Hill. 3. Lucio Bini Mood Disorders Center, New York University Medical Center, and the Child Study Center, New York. 4. The Zucker Hillside Hospital, New York, Northwell Health System, and the Hofstra Northwell School of Medicine, East Garden City, NY.
Abstract
OBJECTIVE: The aim of this study was to meta-analyze the prevalence of symptoms before an initial mood episode of bipolar disorder (BD) and the prevalence of subthreshold symptoms before a BD mood episode recurrence, to facilitate early identification and prevention. METHOD: Systematic literature reviews were conducted in PsycINFO and PubMed for prospective or retrospective studies reporting on the prevalence and longest duration of symptoms before an initial or recurrent mood episode of BD. Random effects meta-regression explored whether geographic location, age, percentage of female individuals, and study quality moderated the overall prevalence. RESULTS: In 11 studies (n = 1,078), the prodrome preceding an initial mood episode lasted 27.1 ± 23.1 months (range, 4.6-130 months). In 10 studies (n = 1,000), the subthreshold symptoms preceding a recurrent mood episode lasted 1.0 ± 0.9 months (range, 0.5-1.3 months). The most common symptoms were largely consistent with diagnostic criteria symptoms associated with the subsequent mood polarity for both the initial prodrome and the period prior to a recurrent mood episode. Few moderators of symptom prevalences emerged, and significant heterogeneity remained. CONCLUSION: The initial prodromal period is sufficiently long and characterized by symptoms of the subsequent mood episode to make early identification and intervention programs feasible. Conversely, the period of subthreshold symptoms before a recurrent mood episode is short, mandating adequate psychoeducation of patients and families, monitoring of changes in sleep and activity, plus sufficiently frequent follow-up visits to identify patients before a mood episode recurrence. Future prospective investigations, designed to address the identified shortcomings in the extant literature, are needed to identify more clinically applicable information.
OBJECTIVE: The aim of this study was to meta-analyze the prevalence of symptoms before an initial mood episode of bipolar disorder (BD) and the prevalence of subthreshold symptoms before a BD mood episode recurrence, to facilitate early identification and prevention. METHOD: Systematic literature reviews were conducted in PsycINFO and PubMed for prospective or retrospective studies reporting on the prevalence and longest duration of symptoms before an initial or recurrent mood episode of BD. Random effects meta-regression explored whether geographic location, age, percentage of female individuals, and study quality moderated the overall prevalence. RESULTS: In 11 studies (n = 1,078), the prodrome preceding an initial mood episode lasted 27.1 ± 23.1 months (range, 4.6-130 months). In 10 studies (n = 1,000), the subthreshold symptoms preceding a recurrent mood episode lasted 1.0 ± 0.9 months (range, 0.5-1.3 months). The most common symptoms were largely consistent with diagnostic criteria symptoms associated with the subsequent mood polarity for both the initial prodrome and the period prior to a recurrent mood episode. Few moderators of symptom prevalences emerged, and significant heterogeneity remained. CONCLUSION: The initial prodromal period is sufficiently long and characterized by symptoms of the subsequent mood episode to make early identification and intervention programs feasible. Conversely, the period of subthreshold symptoms before a recurrent mood episode is short, mandating adequate psychoeducation of patients and families, monitoring of changes in sleep and activity, plus sufficiently frequent follow-up visits to identify patients before a mood episode recurrence. Future prospective investigations, designed to address the identified shortcomings in the extant literature, are needed to identify more clinically applicable information.
Authors: Christopher D Schneck; Kiki D Chang; Manpreet K Singh; Melissa P DelBello; David J Miklowitz Journal: J Child Adolesc Psychopharmacol Date: 2017-07-21 Impact factor: 2.576
Authors: Maria Jalbrzikowski; David Freedman; Catherine E Hegarty; Eva Mennigen; Katherine H Karlsgodt; Loes M Olde Loohuis; Roel A Ophoff; Raquel E Gur; Carrie E Bearden Journal: J Am Acad Child Adolesc Psychiatry Date: 2019-01-18 Impact factor: 8.829
Authors: Danella M Hafeman; Henry W Chase; Kelly Monk; Lisa Bonar; Mary Beth Hickey; Alicia McCaffrey; Simona Graur; Anna Manelis; Cecile D Ladouceur; John Merranko; David A Axelson; Benjamin I Goldstein; Tina R Goldstein; Boris Birmaher; Mary L Phillips Journal: Neuropsychopharmacology Date: 2018-11-08 Impact factor: 7.853
Authors: Anna R Van Meter; Eric A Youngstrom; Boris Birmaher; Mary A Fristad; Sarah M Horwitz; Thomas W Frazier; L Eugene Arnold; Robert L Findling Journal: J Affect Disord Date: 2017-03-14 Impact factor: 4.839
Authors: Nadine M Melhem; Giovanna Porta; Maria A Oquendo; Jamie Zelazny; John G Keilp; Satish Iyengar; Ainsley Burke; Boris Birmaher; Barbara Stanley; J John Mann; David A Brent Journal: JAMA Psychiatry Date: 2019-06-01 Impact factor: 21.596
Authors: Marc J Weintraub; Christopher D Schneck; Patricia D Walshaw; Kiki D Chang; Manpreet K Singh; David A Axelson; Boris Birmaher; David J Miklowitz Journal: J Psychiatr Res Date: 2020-01-25 Impact factor: 4.791
Authors: Boris Birmaher; John A Merranko; Tina R Goldstein; Mary Kay Gill; Benjamin I Goldstein; Heather Hower; Shirley Yen; Danella Hafeman; Michael Strober; Rasim S Diler; David Axelson; Neal D Ryan; Martin B Keller Journal: J Am Acad Child Adolesc Psychiatry Date: 2018-08-07 Impact factor: 8.829
Authors: Marco Solmi; Michele Fornaro; Edoardo G Ostinelli; Caroline Zangani; Giovanni Croatto; Francesco Monaco; Damir Krinitski; Paolo Fusar-Poli; Christoph U Correll Journal: World Psychiatry Date: 2020-06 Impact factor: 49.548